Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum

International Journal of Cancer

Volumn 68, Issue 6, 1996, Pages 782-787

  Wagner, Markus ^a   Cao, Tracy ^a   Lopez, Martha E ^a   Hope, Christopher ^a   Van Nostrand, Kristi ^a,c   Kobrin, Michael S ^a   Fan, Hung U ^a   Büchler, Markus W ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CISPLATIN; HUMANS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, ANTISENSE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0030483560     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961211)68:6<782::AID-IJC16>3.0.CO;2-2     Document Type: Article

References (36)

1. ABOUD-PIRAK, E., HURWITZ, E., PIRAK, M.E., BELLOT, F., SCHLESSINOER, J. and SELA, M., Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma cells in vitro and in nude mice. J. nat. Cancer Inst., 80, 1605-1611 (1988).
2. BASU, A., RAGHUNATH, M., BISHAYEE, S. and DAS, M., Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor in kinase regulation. Mol. cell. Biol., 9, 671-677 (1989).
3. BEAZLEY, R.M. and COHN, I.J., Update on pancreatic cancer. CA Cancer J. Clin., 38, 310-319 (1981).
4. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987).
5. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
6. CHRISTEN, R.D., ISONISHI, S., JONES, J.A., JEKUNEN, A.P., HOM, D.K., KRONING, R., GATELY, D.P., THIEBAUT, F.B., LOS, G. and HOWELL, S.B., Signaling and drug sensitivity. Cancer Metastasis Rev., 13, 175-189 (1994).
7. CHU, G., Cellular response to cisplatin. The roles of DNA-binding proteins and DNA repair. J. biol. Chem., 269, 787-790 (1994).
8. EBERT, M., YOKOYAMA, M., KOBRIN, M.S., FRIESS, H., LOPEZ, M.E., BÜCHLER, M.W., JOHNSON, G.R. and KORC, M., Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res., 54, 3959-3962 (1994).
9. FEINBERO, A.P. and VOGELSTEIN, B., A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13 (1983).
10. GUDJONSSON, B., Cancer of the pancreas. 50 years of surgery. Cancer, 60, 2284-2303 (1987).
11. Guo, C.H., JANOVICK, J.A., KUPHAL, D. and CONN, P.M., Transient transfection of GGH3-1′ cells (GH3 cells stably transfected with the gonadotropin-releasing hormone (GnRH) receptor complementary deoxyribonucleic acid) with the carboxyl-terminal of beta-adrenergic receptor kinase 1 blocks prolactin release: evidence for a role of the G protein beta gamma-subunit complex in GnRH signal transduction. Endocrinology, 136, 3031-3036 (1995).
12. HONEGGER, A.M., SZAPARY, D., SCHMIDT, A., LYALL, R., VAN OBBERGHEN, E., DULL, T.J., ULLRICH, A. and SCHLESSINGER, J., A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate prolo-oncogene expression and DNA synthesis. Mol. cell. Biol., 7, 4568-4571 (1987).
13. HSIAO, W.L., CASTRO, M., GIEZENTANNER, J., FAN, H. and NAECAK, R., Acquisition of responsiveness to chemical carcinogens by rodent embryo fibroblasts expressing high levels of the c-myc protooncogene. Mol. Carcinog., 5, 140-154 (1992).
14. KASHLES, O., YARDEN, Y., FISCHER, R., ULLRICH, A. and SCHLESSINGER, J., A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by neterodimerization. Mol. cell. Biol., 11, 1454-1463 (1991).
15. KOBRIN, M.S., FUNATOMI, H., FRIESS, H., BUECHLER, M.W., STATHIS, P. and KORC, M., Induction and expression of heparinbinding EGF-like growth factor in human pancreatic cancer. Biochem. biophys. Res. Comm., 202, 1705-1709 (1994).
16. KORC, M., Conventional treatment of pancreatic cancer. In: H.G. Beger, M.W. Büchler and P. Malfertheiner (eds.), Standards in pancreatic surgery, pp. 591-594, Springer-Verlag, Berlin (1993).
17. KORC, M., CHANDRASEKAR, B. and SHAH, G.N., Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line. Cancer Res., 51, 6243-6249 (1991).
18. KORC, M., CHANDRASEKAR, B., YAMANAKA, Y., FRIESS, H., BÜCHLER, M.W. and BEGER, E.G., Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. clin. Invest., 90, 1352-1360 (1992).
19. LIVNEH, E., PRYWES, R., KASHLES, O., REISS, N., SASSON, I., MORY, Y., ULLRICH, A. and SCHLESSINGER, J., Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J. biol. Chem., 261, 12490-12497 (1986).
20. MASSAGUÉ, J. and PANCHIETTA, A., Membrane anchored growth factors. Ann. Rev. Biochem., 62, 515-541 (1993).
21. MEYERS, M.B., MERLUZZI, V.J., SPENGLER, B.A. and BIEDLER, J.L., Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells. Proc. nat. Acad. Sci. (Wash.), 83, 5521-5525 (1986).
22. MILLER, A.D. and BUTTIMORE, C., Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. cell. Biol., 6, 2895-2902 (1986).
23. MORIAI, T., KOBRIN, M.S., HOPE, C., SPECK, L. and KORC, M., A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proc. nat. Acad. Sci. (Wash.), 91, 10217-10221 (1994).
24. OGAWA, J., IWAZAKI, M., KOIDE, S. and SHOHTSU, A., Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer. Relation to cisplatin sensitivity. Cancer, 71, 2204-2209 (1993).
25. PAZIN, M.J. and WILLIAMS, L.T., Triggering signaling cascades by receptor tyrosine kinases. Trends biochem. Sci., 17, 374-378 (1992).
26. RAITANO, A.B., SCUDERI, P. and KORC, M., Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. Pancreas, 5, 267-277 (1990).
27. REDEMANN, N., HOLZMANN, B., VON RÜDEN, T., WAGNER, E.F., SCHLESSINGER, J. and ULLRICH, A., Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. cell. Biol., 12, 491-498 (1992).
28. SCHLESSINOER, J. and ULLRICH, A., Growth factor signaling by receptor tyrosine kinases. Neuron, 9, 383-391 (1992).
29. SHANKAR, V., CIARDIELLO, F., KIM, N., DERYNCK, R., LISCIA, D.S., MERLO, G., LANGTON, B.C., SHEER, D., CALLAHAN, R. and BASSIN, R.H., Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA. Mol. Carcinog., 2, 1-11 (1989).
30. SMITH, J.J., DERYNCK, R. and KORC, M., Production of transforming growth factor in human pancreatic cancer cell: evidence for a superagonist autocrine cycle. Proc. nat. Acad. Sci. (Wash.), 84, 7567-7570 (1987).
31. ULLRICH, A. and 14 OTHERS, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309, 418-425 (1984).
32. VELU, T.J., BEQUINOT, L., VASS, W.C., WILLINGHAM, W.C., MERLINO, G.T., PASTAN, I. and LOWY, D.R., Epidermal growth factor-dependent transformation by a human EGR receptor protooncogene. Science, 238, 1408-1410 (1987).
33. WARSHAW, A.L. and FERNANDES-DEL CASTILLO, C., Pancreatic carcinoma. N. Engl. J. Med., 326, 455-465 (1992).
34. WU, X., FAN, Z., MASUI, H., ROSEN, N. and MENDELSOHN, J., Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. clin. Invest., 95, 1897-1905 (1995).
35. YAMANAKA, Y., FRIESS, H., KOBRIN, M., BÜCHLER, M.W., BEGER, H.G. and KORC, M., Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res., 13, 565-570 (1993).
36. YOKOYAMA, M., FUNATOMI, H., KOBRIN, M.S., EBERT, M., FRIESS, H., BUECHLER, M.W. and KORC, M., Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer. Int. J. Oncol., 7, 825-829 (1995).